Skip to main content
. 2017 May 18;9(3):209–215. doi: 10.5114/jcb.2017.67755

Table 3.

Treatment for recurrence

Treatment for recurrence Patients (n)
Time interval from diagnosis of recurrence to radiotherapy (months)
 Median (range) 1.3 (0.1-16.3)
Treatment prior to radiotherapy
 Chemotherapy 3 (8.1%)
 Surgery 1 (2.7%)
 Surgery + chemotherapy 1 (2.7%)
Radiotherapy modality
 ICBT alone 9 (24.35%)
 EBRT + ICBT 14 (37.8%)
 ISBT alone 2 (5.4%)
 EBRT + ISBT 12 (32.4%)
EBRT (Gy)
 Median dose (range) 50 (30-50)
 Median number of fractions (range) 25 (15-25)
Brachytherapy (Gy)
 Median dose (range) 24 (12-54)
 Median number of fractions (range) 4 (2-9)
Cumulative radiotherapy dose (Gy in EQD2)
 Median dose (range) 62 (40-80)

ICBT – intracavitary brachytherapy, ISBT – interstitial brachytherapy, EBRT – external beam radiotherapy, EQD2 – equivalent dose in 2 Gy